<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-054710</identifier>
<setSpec>0213-4853</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Application of the proteomic to neurological diseases</dc:title>
<dc:description xml:lang="en">Proteomic is a set of tools that allows the separation and identification of proteins expressed by a cell, tissue or organism. Two-dimensional electrophoresis is the central tool that allows qualitative and quantitative comparisons of protein patterns between samples. Differential analysis of protein expression patterns in different neurological diseases (stroke, Alzheimer, Parkinson, amyotrophic lateral sclerosis, Hungtington, epilepsy) allows the identification of diagnostic and/or prognostic biomarkers. Subsequently, validation of these markers may help to identify new diagnostic and therapeutic targets</dc:description>
<dc:creator>Sobrino, T</dc:creator>
<dc:creator>Moldes, O</dc:creator>
<dc:creator>Castillo, J</dc:creator>
<dc:creator>Cristobo, I</dc:creator>
<dc:creator>Mosquera, E</dc:creator>
<dc:creator>Brea, D</dc:creator>
<dc:creator>Rodríguez-González, R</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">La proteómica es un conjunto de técnicas que permiten la separación e identificación de las proteínas expresadas por una célula, tejido u organismo. La técnica central de esta disciplina es la electroforesis bidimensional, que permite llevar a cabo comparaciones cualitativas y cuantitativas de los patrones proteicos entre muestras dadas. El análisis diferencial de los patrones de expresión en distintas patologías neurológicas (ictus, Alzheimer, Parkinson, esclerosis lateral amiotrófica, Hungtington, epilepsia) permite la identificación de biomarcadores de diagnóstico y/o pronóstico. La posterior validación de estos marcadores llevaría a la identificación de nuevas dianas diagnósticas y terapéuticas</dc:description>
<dc:source>Neurologia;22(3): 170-179, abr. 2007. ilus</dc:source>
<dc:identifier>ibc-054710</dc:identifier>
<dc:title xml:lang="es">Aplicación de la proteómica a las enfermedades neurológicas</dc:title>
<dc:subject>^d29204</dc:subject>
<dc:subject>^d2512^s22044</dc:subject>
<dc:subject>^d545^s22033</dc:subject>
<dc:subject>^d9611^s22033</dc:subject>
<dc:subject>^d4907^s22044</dc:subject>
<dc:subject>^d704^s22033</dc:subject>
<dc:subject>^d23625</dc:subject>
<dc:subject>^d30920^s22033</dc:subject>
<dc:subject>^d9615^s22044</dc:subject>
<dc:subject>^d34247^s22033</dc:subject>
<dc:subject>^d23923^s22002</dc:subject>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d28048</dc:subject>
<dc:subject>^d545^s22044</dc:subject>
<dc:subject>^d34543^s22045</dc:subject>
<dc:subject>^d9611^s22007</dc:subject>
<dc:subject>^d9611^s22002</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d13441^s22045</dc:subject>
<dc:subject>^d32607</dc:subject>
<dc:subject>^d4907^s22033</dc:subject>
<dc:subject>^d704^s22044</dc:subject>
<dc:subject>^d37630^s22045</dc:subject>
<dc:subject>^d30920^s22044</dc:subject>
<dc:subject>^d9615^s22033</dc:subject>
<dc:subject>^d34247^s22044</dc:subject>
<dc:subject>^d9615^s22016</dc:subject>
<dc:subject>^d2902^s22045</dc:subject>
<dc:subject>^d23923^s22033</dc:subject>
<dc:type>article</dc:type>
<dc:date>200704</dc:date>
</metadata>
</record>
</ibecs-document>
